IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 49 filers reported holding IKENA ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,045 | -30.8% | 15,715 | +4.9% | 0.00% | – |
| Q2 2023 | $98,315 | +111.3% | 14,987 | +11.1% | 0.00% | – |
| Q1 2023 | $46,532 | +376.8% | 13,488 | +267.6% | 0.00% | – |
| Q4 2022 | $9,760 | -94.7% | 3,669 | -92.9% | 0.00% | – |
| Q3 2022 | $183,000 | -44.9% | 51,515 | -31.4% | 0.00% | – |
| Q2 2022 | $332,000 | +325.6% | 75,107 | +481.7% | 0.00% | – |
| Q1 2022 | $78,000 | -49.0% | 12,911 | +6.4% | 0.00% | – |
| Q4 2021 | $153,000 | +273.2% | 12,140 | +275.7% | 0.00% | – |
| Q3 2021 | $41,000 | +720.0% | 3,231 | +787.6% | 0.00% | – |
| Q2 2021 | $5,000 | – | 364 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $30,611,000 | 3.87% |
| Omega Fund Management, LLC | 2,249,123 | $13,720,000 | 2.81% |
| CHI Advisors LLC | 814,755 | $4,970,000 | 2.11% |
| BVF INC/IL | 2,501,571 | $15,260,000 | 0.61% |
| Artal Group S.A. | 1,549,513 | $9,452,000 | 0.40% |
| Orbimed Advisors | 2,933,941 | $17,897,000 | 0.29% |
| Logos Global Management LP | 178,281 | $1,088,000 | 0.14% |
| HealthCor Management, L.P. | 287,621 | $1,754,000 | 0.12% |
| FARALLON CAPITAL MANAGEMENT LLC | 792,077 | $4,832,000 | 0.02% |
| Point72 Asset Management, L.P. | 348,696 | $2,127,000 | 0.01% |